Cited by 466Neuroinflammation and Neurodegeneration MechanismsPluripotent Stem Cells ResearchNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Development and validation of a simplified method to generate human microglia from pluripotent stem cells

Open access

McQuade, Amanda, Coburn, Morgan, Tu, Christina H., Hasselmann, Jonathan, Davtyan, Hayk, Blurton-Jones, Mathew·2018·Molecular Neurodegeneration

DOI 10.1186/s13024-018-0297-xPMC PMC6303871

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Microglia, the principle immune cells of the brain, play important roles in neuronal development, homeostatic function and neurodegenerative disease. Recent genetic studies have further highlighted the importance of microglia in neurodegeneration with the identification of disease risk polymorphisms in many microglial genes. To better understand the role of these genes in microglial biology and disease, we, and others, have developed methods to differentiate microglia from human induced pluripotent stem cells (iPSCs). While the development of these methods has begun to enable important new studies of microglial biology, labs with little prior stem cell experience have sometimes found it challenging to adopt these complex protocols. Therefore, we have now developed a greatly simplified approach to generate large numbers of highly pure human microglia. RESULTS: hematopoietic progenitors are then simply transferred to media that includes three key cytokines (M-CSF, IL-34, and TGFβ-1) that promote differentiation of homeostatic microglia. This updated approach avoids the prior requirement for hypoxic incubation, complex media formulation, FACS sorting, or co-culture, thereby significantly simplifying human microglial generation. To confirm that the resulting cells are equivalent to previously developed iPSC-microglia, we performed RNA-sequencing, functional testing, and transplantation studies. Our findings reveal that microglia generated via this simplified method are virtually identical to iPS-microglia produced via our previously published approach. To also determine whether a small molecule activator of TGFβ signaling (IDE1) can be used to replace recombinant TGFβ1, further reducing costs, we examined growth kinetics and the transcriptome of cells differentiated with IDE1. These data demonstrate that a microglial cell can indeed be produced using this alternative approach, although transcriptional differences do occur that should be considered. CONCLUSION: We anticipate that this new and greatly simplified protocol will enable many interested labs, including those with little prior stem cell or flow cytometry experience, to generate and study human iPS-microglia. By combining this method with other advances such as CRISPR-gene editing and xenotransplantation, the field will continue to improve our understanding of microglial biology and their important roles in human development, homeostasis, and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13024-018-0297-x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 A simplified microglial differentiation protocol can be used to produce large numbers of highly pure human microglia. Schematic showing the process of differentiation from iPSCs through the mesoderm lineage (days 0–3) and further promoting hematopoiesis (days 3–11). Primitive hematopoietic progenitor cells begin to appear on day 7 (black arrows) and by day 11 large numbers of round non-adherent HPCs are observed. Floating HPCs are then transferred into new medium to induce microglial differentiation for 27 days. The last 3 days of microglial differentiation include additional neuronal and astrocytic ligands to further educate microglia toward a brain-like, homeostatic environment. By day 38, large numbers of highly pure microglia that stain positively for both P2RY12 and TREM2 (> 94%) have been produced and are ready for experimentationCC BY · PubMed Central

Fig. 2 iPS-microglia 2.0 are virtually identical to iPS-microglia generated using a more complex protocol. a Principle component analysis demonstrates that iPS-microglia 2.0 (dark blue) and iPS-microglia differentiated using our previously published protocol (blue) exhibit highly equivalent gene expression profiles that cluster closely with cultured human fetal and adult microglia (light blue and teal). Additionally, these cells are distinct from human CD14+ monocytes (purple) and CD16+ inflammatory monocytes (pink), and dendritic cells (maroon). b Principal component analysis using a gene list enriched for 882 microglial genes from (Gosselin et al., 2017), further demonstrates the equivalent gene expression between iPS-microglia and fetal and adult microglia. This analysis also highlights the trajectory of differentiation from iPSCs to Microglia and shows the separation between our protocol and monocytic and dendritic cell populations. c Volcano plot of differential expression analysis (p < 0.001, log2(FC) > 2) between iPS-HPC and iPS-HPC 2.0 samples (top) as well as iPS-microglia and iPS-microglia 2.0 (bottom). Significantly increased or decreased genes are shown in coral or blue respectively. d Heatmap using 882 microglial-enriched genes further demonstrates the highly similar gene expression profiles between iPS-microglia and iPS-microglia 2.0 and the close similarity of both cell populations to fetal and adult cultured microgliaCC BY · PubMed Central

Fig. 3 iPS-microglia 2.0 are distinct from CD14+ and CD16+ monocytes Microglia differentiated using our published protocol are distinct from CD14+ monocytes and CD16+ inflammatory monocytes. In order to ensure our iPS-microglia 2.0 are similarly distinct from monocytes, differential expression analysis was computed with DEseq2. a Volcano plots of differentially expressed genes comparing genes enriched in CD16+ monocytes (pink) with genes enriched in iPSmicroglia 2.0 (dark blue) or iPS-microglia (light blue) show many significant differences between monocytes and microglia. Venn diagrams and comparative fold change plots of differentially expressed genes show that the vast majority of differences are identical between iPS-microglia and iPS-microglia 2.0 when compared to CD16+ monocytes. Direct comparisons of the fold change expression level (TPM) of every gene are shown in comparative fold change plots which demonstrate the striking similarity of differential expression when iPS-microglia and iPS-microglia 2.0 are each compared to CD16+ monocytes. b The same is true for comparisons of iPS-microglia and iPS-microglia 2.0 with CD14+ monocytes (purple)CC BY · PubMed Central

Fig. 4 iPS-microglia 2.0 exhibit equivalent substrate-dependent phagocytosis. iPS-microglia and iPS-microglia 2.0 were exposed to fluorescent beta-amyloid fibrils, pHrodo tagged S. aureus, or pHrodo tagged Zymosan A bioparticles from S. cerevisiae. Quantification of the percent of total cells with positive fluorescent signal and the mean fluorescence intensity of that signal is shown on the left. No significance differences were found between each differentiation type, demonstrating the equivalent functional activity of microglia generated by these two differentiation paradigms. Representative images of phase, CD45 staining, and the fluorescent signal of beta-amyloid (top), S. aureus (middle), and Zymosan A (bottom) are shown on the right. One representative image of 10,000 quantified images is shown for iPS-microglia 2.0 (top of each set) and iPS-microglia (bottom of each set)CC BY · PubMed Central

Fig. 5 Transplanted iPS-microglia 2.0 display typical microglial markers and morphology comparable to our previously described iPS-microglia. Adult 2 month old MITRG mice were transplanted with (a-d & i-j, top rows) iPS-microglia 2.0 or (e-h & m-p, bottom rows) iPS-microglia. Brains were harvested 2 months post-transplant. Representative images of cortical (a-h) and hippocampal (i-p) transplanted cells demonstrate complex process ramification and typical tiling. Transplanted iPS-microglia and iPS-microglia 2.0 both express Iba-1 (Overlay images c, g, k, & o, red) and the microglia specific marker, P2RY12 (Overlay images d, h, l, & p, red) and demonstrate human nuclear staining (Ku80, green). Additionally, transplanted human microglia can be seen integrating and tiling with the endogenous mouse microglia population (Arrows indicate Iba1+/Ku80- cells)CC BY · PubMed Central

Fig. 6 The small molecule compound IDE1 can be used in place of TGFβ-1 to produce iPS-microglia. IDE1 and IDE2 were added to microglia cultures in place of TGFβ-1 at the indicated concentrations. a Growth curves from the first 3.5 days of microglial differentiation show that IDE2 is insufficient to allow proliferation of these cells. In contrast, IDE1 (blue) at lower concentrations shows similar growth kinetics to TGFβ control cells (green). b Correlation matrix displaying all samples analyzed in this manuscript shows cells differentiated with IDE1 cluster closely with iPS-microglia 2.0 and are actually more similar to fetal and adult microglia than TGFβ control microglia. c Gene ontology analysis using the Reactome database displays differences between IDE1 treated cells and TGFβ (FDR < 0.001, FC > 2). Enrichment in IDE samples reflects an increased expression of genes within this GO family in IDE1 treated cellsCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Near-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154
Self-citation
Differential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models
Friedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662

Show all 33 references

Sorted by citations

Items 301–400 of 466

Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer’s Disease
Hu, M., Li, A. Z., Fleming, P., Gralla, J., Terón, K. I. N., Zhou, Y., Miller, E. J., Beyett, T. S., Wen, Z., Du, Y., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01425 · Cited by 3
Microglial reactivity and nodule formation are associated with Synaptodendritic damage in the brains of people with HIV ‐1
Reis, R. S., Ignatz, L. A., Selvam, S., Wagner, M. C. E., Gianella, S., Chaillon, A., Gomez‐Moreno, V., Martison, J., Rubin, L. H., Haberlen, S., et al. (2025) · Brain Pathology · doi:10.1111/bpa.70064 · Cited by 3
Navigating the frontier of human microglia isolation—standardization and translational insight
Pal, P., Sharma, M., & Gupta, S. K. (2026) · Methods · doi:10.1016/j.ymeth.2026.01.002 · Cited by 4
Microglia beyond boundaries: Paradigm shifts in origin, distribution, state diversity, and therapeutic regeneration
Lan, Z., Liu, H., Huang, C., Li, J. R., Dai, Z., Yuan, Y. Z., He, C., Qin, S., & Su, Z. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106170 · Cited by 4
Organelle phenotyping and multi‐dimensional microscopy identify C1q as a novel regulator of microglial function
Sakthivel, P. S., Scipioni, L., Karam, J. D., Keulen, Z., Blurton-Jones, M. M., Gratton, E., & Anderson, A. J. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16173 · Cited by 3
Self-citation
Derivation of a Human Brain Organoid with Microglia Development
Wang, T., Gastfriend, B. D., McDonald, V., Steiner, J. P., Elkahloun, A. G., & Nath, A. (2025) · Journal of Visualized Experiments · doi:10.3791/67491 · Cited by 3
Familial Alzheimer's disease mutation identifies novel role of SORLA in release of neurotrophic exosomes
Juul‐Madsen, K., Rudolph, I., Gomes, J. P., Meyer, K., Ovesen, P. L., Gorniak‐Walas, M., Kokoli, M., Telugu, N. S., Sivertsen, M. V. T., Febbraro, F., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70591 · Cited by 2
Improving mouse models for the study of Alzheimer's disease
Reagan, A. M., Onos, K. D., Heuer, S. E., Sasner, M., & Howell, G. R. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2021.12.005 · Cited by 5
Anatomical location of injected microglia in different activation states and time course of injury determines survival of retinal ganglion cells after optic nerve crush
Siddiqui, A. M., Sabljic, T. F., & Ball, A. K. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2142579 · Cited by 3
Targeting and eradicating latent CNS reservoirs of HIV-1: Original strategies and new models
Saeb, S., Wallet, C., Rohr, O., Schwartz, C., & Loustau, T. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115679 · Cited by 6
POU3F2 regulates canonical Wnt signalling via SOX13 and ADNP to expand the neural progenitor population
Benoit, C. R., Sattler, L. B., Aylward, A. J., Pembridge, O. G., Kim, B., Muratore, C., Liao, M., He, A., Ashour, N., Fancher, S. B., et al. (2025) · Brain · doi:10.1093/brain/awaf221 · Cited by 3
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk
Dodd, R. B., Enomoto, M., Zhou, Y., Satoh, K., Zhang, Y., Chen, F., Acheson, B., Ghaffari, D., Sayn-Wittgenstein, E., Manning, J. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75140-3 · Cited by 4
PSEN1 M146V and PSEN1 A246E mutations associated with Alzheimer’s disease impair proper microglia differentiationPreprint
Aubert, A., Mendoza-Ferri, M. G., Bramoulle, A., Stüder, F., Colombo, B. M., & Mendoza-Parra, M. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.08.561397 · Cited by 3
Cell autonomous microglia defects in a stem cell model of frontotemporal dementiaPreprint
Iyer, A. K., Vermunt, L., Mirfakhar, F. S., Minaya, M., Acquarone, M., Koppisetti, R. K., Renganathan, A., You, S., Danhash, E., Verbeck, A. C., et al. (2024) · medRxiv · doi:10.1101/2024.05.15.24307444 · Cited by 3
An aging-sensitive compensatory secretory phospholipase that confers neuroprotection and cognitive resiliencePreprint
Vicidomini, C., Goode, T. D., McAvoy, K. M., Yu, R., Beveridge, C. H., Iyer, S. N., Victor, M. B., Leary, N., Evans, L., Steinbaugh, M. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.26.605338 · Cited by 4
HIV-1 infection of human microglia activates inflammatory pathways associated with HIV-associated neurocognitive disorders (HAND)Preprint
Hammonds, J. E., Moscona, R., Candor, K., Guthier, H., Kumaragurubaran, R., Hagan, T., & Spearman, P. W. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638028 · Cited by 5
Development and characterization of in vitro inducible immortalization of a murine microglia cell line for high throughput studies
Yeh, H., Cruz, M. A. D., You, Y., Ikezu, S., & Ikezu, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-87543-1 · Cited by 2
A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation
Harkin, J., Gomes, C., Afify, R. A. A., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522958123 · Cited by 3
Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in C9orf72 -ALS/FTD Microglia
Thiry, L., Pulimood, N. S., Tang, Y. M., & Stifani, S. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2542998 · Cited by 4
Human microglia reduce alpha-synuclein aggregation and are neuroprotective in adult mouse brain
Albert, K., Peltonen, S., Vanne, A., Kälvälä, S., Syvänen, V., Koıstınaho, J., Luk, K. C., & Lehtonen, Š. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106097 · Cited by 3
A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis, and hypoglycemia
Simha, V., LoPiccolo, M. K., Platt, A., Brown, R. J., Johnson, X., Carere, D. A., Donnelly, C. M., Snyder, M. T., Xing, C., Mathews, T. P., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci198888 · Cited by 2
Comparative lipidomics of iPSC-derived microglia protocols reveal lipid droplet and immune differences mediated by media composition
Robert, A., McQuade, A., Hertog, S. K.-D., Erlebach, L., Kronenberg‐Versteeg, D., Kampmann, M., Giera, M. A., & van der Kant, R. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102779 · Cited by 2
Self-citation
Protocol for morphogen-guided differentiation of brain cell types using human induced pluripotent stem cells
Qian, L., Rosa, J. S., & Julia, T. C. W. (2026) · STAR Protocols · doi:10.1016/j.xpro.2025.104339 · Cited by 2
Mll5 haploinsufficiency attenuates microglial phagocytosis through dysregulated TREM2-SGK3-GSK3β signaling and recapitulates ASD-like behaviors in mice
Gao, S., Lin, Q., Liu, X., Jia, M., Zhang, A.-Y., Feng, Z., Han, L., Qiu, N., Liu, X., Zhai, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71922-x · Cited by 2
Tgf-β receptor signaling cell-intrinsically controls conserved microglia homeostatic maturation during zebrafish development
Miserocchi, M., Meyer, P. D., Lattuca, R., Montanari, A., Ferrero, G., Boezio, G. L. M., Stainier, D. Y. R., & Wittamer, V. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117795 · Cited by 2
Cholesterol dysregulation in APOE4 astrocytes promotes α-synuclein pathology in miBrains
Mesentier-Louro, L. A., Goldman, C., Gaese, S., Buonfiglioli, A., Kyriakis, D., Harlock, A., Ndayisaba, A., Sartori, E. R., Uchitelev, A., Fullard, J. F., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.001 · Cited by 6
An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience
Vicidomini, C., Goode, T. D., Yu, R., Mehta, I. K., McAvoy, K. M., Beveridge, C. H., Randolph, C. E., Iyer, S. N., Victor, M. B., Leary, N., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02465-z · Cited by 2
CIRM tools and technologies: Breaking bottlenecks to the development of stem cell therapies
Collins, L. R., & Shepard, K. A. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0055 · Cited by 2
Bipolar disorder as a gliopathy
Stertz, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00015-6 · Cited by 2
Glial cell transplant for brain diseases: the supportive saviours?
Albert, K., Goldsteins, G., Kälvälä, S., Jolkkonen, J., & Lehtonen, Š. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00182-y · Cited by 3
Protocol to assess engulfment and degradation of synaptosomes by murine microglia in vitro
Matera, A., Compagnion, A., & Paolicelli, R. C. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.103936 · Cited by 3
Cellular and molecular neurobiology of autism spectrum disorder
Chapman, G., Antony, I., Narasimhan, M., Shen, R., Elman, R., & Kroll, K. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-816393-1.00007-5 · Cited by 2
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathologyPreprint
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J. S., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind-Mark, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.08.451574 · Cited by 2
Systematic comparison of culture media uncovers phenotypic shift of human microglia defined by reduced reliance to CSF1R signalingPreprint
Dorion, M., Yaqubi, M., Murdoch, H. J., Hall, J. A., Dudley, R., Antel, J. P., Durcan, T. M., & Healy, L. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.14.500101 · Cited by 2
The A53T mutation in α-synuclein enhances pro-inflammatory activation in human microgliaPreprint
Krzisch, M., Yuan, B., Chen, W., Osaki, T., Fu, D., Garrett-Engele, C. M., Svoboda, D. S., Andrykovich, K. R., Sur, M., & Jaenisch, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.29.555300 · Cited by 2
ER and SOCE Ca 2+ signals are not required for directed cell migration in human microgliaPreprint
Granzotto, A., McQuade, A., Chadarevian, J. P., Davtyan, H., Sensi, S. L., Parker, I., Blurton-Jones, M. M., & Smith, I. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.18.576126 · Cited by 2
Self-citation
A novel induced pluripotent stem cell model of Schwann cell differentiation reveals NF2 - related gene regulatory networks of the extracellular matrixPreprint
Lazaro, O., Li, S., Carter, W., Awosika, O., Robertson, S., Hickey, B. E., Angus, S. P., House, A., Clapp, D. W., Qadir, A. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.02.591952 · Cited by 2
HIV-1 infection promotes neuroinflammation and neuron pathogenesis in novel microglia-containing cerebral organoidsPreprint
Narasipura, S. D., Zayas, J. P., Ash, M. K., Reyes, A. F., Shull, T. L., Gambut, S., Schneider, J. R., Lorenzo-Redondo, R., Al‐Harthi, L., & Mamede, J. I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.13.598579 · Cited by 2
A proteogenomic tool uncovers protein markers for human microglial statesPreprint
Haage, V. C., Bautista, A. R., Tuddenham, J. F., Marshe, V. S., Chiu, R., Liu, Y., Lama, T., Kelly, S. S., Parghi, N., Park, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.31.646212 · Cited by 3
APOE4 promotes cerebrovascular fibrosis and amyloid deposition via a pericyte-to-myofibroblast transitionPreprint
Schuldt, B. R., Haworth-Staines, D., Arévalo, A. P., Broekaart, D. W. M., Harlock, A., Wang, L., Bright, A., Gallagher, G., Rabinowitz, G., Goate, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.04.674192 · Cited by 2
Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers
Jeskanen, H., Heikkinen, S., Kervinen, I., Lehtisalo, J., Ngandu, T., Willman, R.-M., Rosa, J., Hoffmann, D., FinnGen, Leinonen, V., et al. (2026) · Alzheimer's Research & Therapy · doi:10.1186/s13195-026-01957-1 · Cited by 1
“TREM2 deficiency leads to impaired microglial response to β-amyloid plaques, accumulation of the lipid droplets, and increased β-amyloid load in the brain [11, 41].”
Establishing validity standards for iPSC modeling of neuropsychiatric disorders
Kolsters, N., Vernon, A. C., Kasri, N. N., & Latour, B. L. (2025) · Genomic psychiatry : · doi:10.61373/gp025p.0074 · Cited by 1
C1q-CD44 interactions regulate microglial phagocytosis, proliferation, and migration
Sakthivel, P. S., Villegas, A. J., Lakatos, A., Kaipa, M., Lopez, J. M., Ling, A., Elrachid, Z. H., Karam, J. D., & Anderson, A. J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03892-2 · Cited by 1
Protocol for the removal of bound endotoxin from tau protein produced in Escherichia coli
Shultz, A., Mena, D., Roy, J. L., Nulman, J., & Rauch, J. N. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.104177 · Cited by 1
Engineering a Perfusion Bioreactor System for hiPSC‐Derived Progenitor Co‐Culture Capturing Microglial Features in CNS Development
Gomes, C. M., de Sá, I., Delgado, M., Alves, P. M., & Brito, C. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.70100 · Cited by 1
iPSC-derived microglia: Decoding roles and therapeutic opportunities in neurodegenerative diseases
Shan, D., Wang, H., Li, J., Tang, Y., Zhan, Z., Yan, C., Xu, J., & Liu, F. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111779 · Cited by 1
Microglia at the core of brain inflammaging: advanced in vitro and neuroimmune organoid platforms for neurotheranostics
Komleva, Y. K., Satish, A., Berdnikov, A. K., Rozanova, N. A., Kolotyeva, N. A., Tregub, P. P., Saridis, M. R., Yurchenko, S. O., & Salmina, A. B. (2026) · The European Physical Journal Special Topics · doi:10.1140/epjs/s11734-026-02209-x · Cited by 2
LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation
MacDougall, E. J., Chen, C. X. ‐., Deneault, É., You, Z., Kalaydjian, D., Abdian, N., Durcan, T. M., Senkevich, K. A., Gan‐Or, Z., & Fon, E. A. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01310-1 · Cited by 3
CSF1R T567M mutation induces microglial dysfunction and synaptic impairment in patient iPSC-derived cerebral organoids of CSF1R-related disorder
Chi, L., Tu, H., Li, Z., Qiu, L., Zhang, Z., Chia, S., Tan, J. Y., Ho, I. A. W., Loh, Y., Tan, E., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02995-2 · Cited by 1
Dissecting microglial contributions to neurodegenerative disease pathophysiology using human pluripotent stem cells
Kim, D., Kondo, T., & Inoue, H. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102866 · Cited by 1
Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model
Rajamanickam, S., Trescott, S., Mak, S., Warden, A. S., Wilpitz, A., Xia, B., Nguyen, C. T., Ding, H., Picarsic, J. L., Glass, C. K., et al. (2026) · Blood · doi:10.1182/blood.2025032207 · Cited by 1
Proteomic comparison of human neural cell-derived extracellular vesicles and parental cells from Alzheimer’s disease and cognitively normal individuals
Xin, J., Liu, J., Dong, H.-M., Yu, H., Xiao, Z., Hu, J.-N., Jiang, Q., Zhu, Y.-P., Feng, L., Feng, Y., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3243-2 · Cited by 2
Modeling stimulus-induced stress responses in microglia-like cells using a commercial iPSC-dCas9-KRAB line
Saunders, D. M., Kearns, N. A., Ng, B., Sultan, F. A., Vyas, H., Vialle, R. A., Clark, E. M., Tissera, S. L. D., Xu, J., Bennett, D. A. A., et al. (2026) · Stem Cell Research · doi:10.1016/j.scr.2026.104017 · Cited by 1
Disease-associated RNA and protein signatures in iPSC-derived microglia model of Alzheimer’s disease
Wu, W., Choi, E. S., Liu, L., Thamilselvan, V., LI, L., Rippee‐Brooks, M. D., Khatkar, K., Li, D.-Y., McGrath, D., Manning, A. C., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1799542 · Cited by 1
HMC3 revealed: how much do these “Microglia” really tell us?
Buccarello, L., Privitera, A., Partsinevelos, K., Serwa, K., Carota, G., Pietro, L. D., Cardaci, V., Mangione, R., Sibbitts, J., Lazzarino, G., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1778798 · Cited by 2
Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
Özata, G., Wise, R. M., Cardona‐Alberich, A., Mayeen, N. F., Müller, S. A., Lichtenthaler, S. F., Zecca, L., & Burbulla, L. F. (2026) · Scientific Reports · doi:10.1038/s41598-026-55648-w · Cited by 1
Neuroinflammation in glaucoma: a myriad of cellular pathways and players
MacLean, M., Lydon, S. D., Gomes, C., Pizzi, E. M., Diemler, C. A., Yablonski, S. E. R., Howell, G. R., Meyer, J. S., & Libby, R. T. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10253-0 · Cited by 1
Emerging Regenerative Medicine for Spinal Cord Injury: Spinal Cord Organoids-on-a-Chip
Khan, M., Choi, H., Ahmad, S., Lee, S., Park, J., & Han, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27157060 · Cited by 1
Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks
Mordelt, A., Schuurmans, I. M. E., Scheefhals, N., Hommersom, M. P., Slottje, K., Mast, K., Graziani, M., González, C. O., Mulder, K. W., Wingens, L., et al. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103053 · Cited by 5
Herpesvirus Infections in the Human Brain: A Neural Cell Model of the Complement System Derived from Induced Pluripotent Stem Cells
Marques, E. T. A., Demers, M., D’Aiuto, L., Castanha, P. M. S., Yeung, J., Wood, J. A., Chowdari, K. V., Zheng, W., Yolken, R. H., & Nimgaonkar, V. L. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_383 · Cited by 1
Human models as new tools for drug development and precision medicine
Dei-Ampeh, A. K., Shah, M. M., Cappuccio, G., Young, D. W., & Maletić‐Savatić, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822277-5.00004-3 · Cited by 1
The versatile applications of human pluripotent stem cell-derived microglia and microglia-containing brain organoids
Wu, J., & Tang, Y. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.01 · Cited by 1
Stem cell engineering approaches for investigating glial cues in central nervous system disorders
Vardhan, S., Jordan, T., & Sakiyama‐Elbert, S. E. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103131 · Cited by 1
Transcriptomic profiling of human iPSC-derived Schwann-like cells reveals NF2-regulated gene regulatory networks
Lazaro, O., Li, S., Smiley, J. S., Carter, W., House, A., Awosika, O., Robertson, S., Haskell, A. K., Hinkel, R. D., Hickey, B. E., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-69205-y · Cited by 1
Roots of Progress: Uncovering Cerebellar Ataxias Using iPSC Models
Giacich, M., Naef, V., Santorelli, F. M., & Damiani, D. (2025) · Biomedicines · doi:10.3390/biomedicines13092121 · Cited by 2
Gene regulatory networks underlying human microglia maturationPreprint
Han, C. Z., Li, R. Z., Hansen, E. A., Bennett, H. R., Poirion, O., Buchanan, J., Challacombe, J. F., Fixsen, B. R., Trescott, S., Schlachetzki, J. C. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.02.446636 · Cited by 1
MerTK mediates the immunologically silent uptake of alpha-synuclein fibrils by human microgliaPreprint
Dorion, M., Senkevich, K. A., Yaqubi, M., Kieran, N. W., Chen, C. X. ‐., MacDonald, A., Luo, W., Wallis, A., Shlaifer, I., Hall, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.04.531108 · Cited by 1
Proximity Proteome Analysis Reveals Novel TREM2 Interactors in the ER-Mitochondria Interface of Human MicrogliaPreprint
Kwak, C. S., Finan, G. M., Park, Y. R., Garg, A., Harari, O., Mun, J. Y., Rhee, H., & Kim, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.21.533722 · Cited by 1
Uptake of alpha-synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microgliaPreprint
Niskanen, J., Peltonen, S., Ohtonen, S., Fazaludeen, M. F., Luk, K. C., Giudice, L., Koıstınaho, J., Malm, T., Goldsteins, G., Albert, K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4021601/v2 · Cited by 1
GPCR-targeted imaging and manipulation of homeostatic microglia in living systemsPreprint
Chandrasekharan, S. V., Chaubey, P., Khandelwal, S., Medishetti, R., Chakraborty, S., Rajaram, S., Jayakumar, K., Latua, P., Goyal, R., Gopalakrishna, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646501 · Cited by 1
KOLF2.1J iTF-Microglia: A standardized platform to study microglial transcriptional regulatory networks in CNS diseasePreprint
Rodríguez-Nunez, I., Bartley, S. C., Taylor, J. W., Johnston, S. Q., Rogers, B. B., Meadows, S. K., Newberry, K. M., Cochran, J. N., & Myers, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.30.657077 · Cited by 1
Human induced pluripotent stem cell-derived microglia with a CX3CR1-V249I genetic variant exhibit dysfunctional phenotypes and modulate neuronal growth and functionPreprint
Tutrow, K. D., Harkin, J., Varghese, L., Hernandez, M., Huang, K.-C., Fang, Y., Wilcox, P., Bedford, L. M., Lin, T., Zhang, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.01.662163 · Cited by 1
Stress-Responsive Transcriptomic Signatures in Human iPSC-Derived Microglia Reveal Links to Alzheimer’s Disease Risk GenesPreprint
Saunders, D., Sultan, F. A., Vialle, R. A., Kearns, N. A., Ng, B., Clark, E. M., Vyas, H., Tissera, S. L. D., Xu, J., Bennett, D. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.30.673269 · Cited by 1
LRRK2 Kinase Mediates Increased GCase Activity in Microglia in Response to Proinflammatory StimuliPreprint
MacDougall, E. J., Chen, C. X. ‐., Deneault, É., You, Z., Abdian, N., Durcan, T. M., Senkevich, K. A., Gan‐Or, Z., & Fon, E. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681687 · Cited by 1
MEA-LINK identifies the CCL4-CCR5 axis in neuronal hyperactivity control by human microgliaPreprint
Mordelt, A., Scheefhals, N., Schuurmans, I. M. E., Slottje, K., Rivera, M. C., Hommersom, M. P., Huang, A., Bichmann, L., Lewerissa, E., van Hugte, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.04.703799 · Cited by 1
A validated antibody toolbox for ALS researchPreprint
Ayoubi, R., MacDougall, E. J., McDowell, I., Biddle, M., Ferreira, B. T., Zha, C., Dorion, M., Ross, J. P., Bolívar, S. G., Moleón, V. R., et al. (2026) · eLife · doi:10.7554/elife.111349.1 · Cited by 1
Differentiation of iPSC into Microglia-Like Cells (iMGL) v1Preprint
Filipello, F., Marsh, J. A., Martinez, R., & Karch, C. M. M. (2020) · doi:10.17504/protocols.io.be43jgyn
Canine induced pluripotent stem cells: an in vitro approach to validate the dog as a large animal model for Alzheimer’s disease
Pessôa, L. V. D. F., Chandrasekaran, A., Thomsen, B. B., Berendt, M., Hyttel, P., & Freude, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822228-7.00010-2
[Facioacromelic disostosis with metal retardation (author's transl)].
Cantú, J. M., Hernández, A., Nazará-Cazorla, Z., Pacheco, C., & Armendares, S. (1974) · PubMed
Loss of function in the autism and schizophrenia-associated gene CYFIP1 in human microglia supports a role in synaptic pruningPreprint
Sheridan, S. D., Horng, J. E., Yeh, H., McCrea, L. T., Fu, T., & Perlis, R. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.24.513576
Investigação do papel da Microglia derivada de iPSC no Transtorno do Espectro do Autismo.
Castanha, A. G. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2022.tde-18042022-145828
Transcriptome-guided optimization of in vitro culture conditions to study microglia in health and disease
Timmerman, R. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1603
An adapted stem cell-derived microglia protocol for the study of microgliopathies and other neurological disordersPreprint
Dorion, M., Casas, D., Yaqubi, M., Fleming, P., Chen, C. X. ‐., Piscopo, V. E. C., Nicouleau, M., Goldsmith, T., Shlaifer, I., MacDonald, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556933
Generation of a human embryonic stem cell reporter line, TMEM119-EGFP, for the visualisation of in vitro differentiated human microglia
Denman, C. R., Tran, H., Shin, M., Ryu, J., Kühn, B., & Jo, J. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103264
A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's DiseasePreprint
Haage, V. C., Tuddenham, J. F., Comandante-Lou, N., Bautista, A. R., Monzel, A. S., Chiu, R., Fujita, M., Garcia, F. G., Bhattarai, P., Patel, R., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4755485
Roles of Ipsc in Advancing Treatments for Neurological DisordersPreprint
Zhang, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4818803
An aging-sensitive compensatory secretory phospholipase that confers neuroprotection and cognitive resiliencePreprint
Sahay, A., Vicidomini, C., Goode, T. D., McAvoy, K. M., Yu, R., Beveridge, C. H., Iyer, S. N., Victor, M. B., Leary, N., Steinbaugh, M. J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4920738/v1
Protective variant in PLCγ2 mitigates Alzheimer’s disease-associated pathologies via enhancing beneficial microglia functionsPreprint
Takalo, M., Jeskanen, H., Rõlova, T., Kervinen, I., Hellén, M., Heikkinen, S., Koivisto, H., Jokivarsi, K. T., Müller, S. A., Koivumäki, E.-M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.12.612207
Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitroPreprint
Podleśny-Drabiniok, A., Romero-Molina, C., Patel, T., Wen, Y.-S., Liu, Y.-Y., Marcora, E., & Goate, A. (2024) · bioRxiv · doi:10.1101/2024.10.24.619910 · Cited by 7
Generation of a human induced pluripotent stem cell line (BIHi292-A) from PBMCs of a female patient diagnosed with Nasu-Hakola disease (NHD)/polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) carrying a novel heterozygous mutation in the TREM2 gene
Göttert, R., Vallone, V. B. F., Stachelscheid, H., Metzger, J. J., Caedo, C. C., Buthut, M., Prüß, H., Endres, M., Schilling, S., & Gertz, K. R. (2025) · Stem Cell Research · doi:10.1016/j.scr.2025.103660
SAMHD1 Knockout iPSC model enables high lenti-viral transduction in myeloid cell typesPreprint
Li, H., Afroze, M., Arora, G., Federman, S., Shevade, K., Yang, Y. A., Nguyen, P., Esanov, R., Przybyla, L., Litterman, A. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.04.636295
Dysregulated expression of inflammasome and extracellular matrix genes in C9orf72 -ALS/FTD microgliaPreprint
Pulimood, N. S., Thiry, L., Tang, Y. M., & Stifani, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638162
Rewired m6A methylation of promoter antisense RNAs in Alzheimer’s disease regulates global gene transcription in the 3D nucleomePreprint
Hu, B., Shi, Y., Xiong, F., Chen, Y.-T., Zhu, X., Carrillo, E. C., Wen, X., Drolet, N. A., Rajpurohit, C. S., Xu, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.22.644756
SAMHD1 knockout hiPSC model enables high lentiviral transduction efficiency in myeloid cell types
Li, H., Afroze, M., Arora, G., Federman, S., Shevade, K., Yang, Y. A., Nguyen, P., Esanov, R., Przybyla, L., Litterman, A. J., et al. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1574545
Familial Alzheimer disease mutation identifies novel role of SORLA in release of neurotrophic exosomesPreprint
Juul‐Madsen, K., Rudolph, I., Gomes, J. P., Meyer, K., Ovesen, P. L., Górniak-Walas, M. J., Kokoli, M., Telugu, N. S., Sivertsen, M. V. T., Sutherland, D. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.649924
A proteogenomic tool uncovers protein markers for human microglial statesPreprint
Jager, P. L. D., Haage, V. C., Bautista, A. R., Tuddenham, J. F., Marshe, V. S., Chiu, R., Liu, Y., Lama, T., Kelly, S. S., Parghi, N., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6380446/v1
Mll5 haploinsufficiency attenuates microglial phagocytosis through dysregulated TREM2-SGK3-GSK3β signaling in autismPreprint
Gao, S., Lin, Q., Liu, X., Jia, M., Zhang, A., Feng, Z., Han, L., Qiu, N., Zhai, H., Zhang, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6665030/v1
Emerging Human Choroid Plexus Organoid Models for Blood-CSF Barrier Research
Qiao, H., & Zhao, Z. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_4
ELTD1 inhibits differentiation of hemogenic endothelium progenitors from human embryonic stem cells through the HPIP–Wnt pathway
Luo, Q., Chen, Y., Li, H., Long, Y., Shan, W., Zeng, X., Cai, S., Meng, Y., Wei, C., Xu, Y., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01473-6
Innate immunocompetent iNSpheroids: A hiPSC-derived 3D model to study the central nervous system captures an early CNS response to rAAVPreprint
Gomes, C. M., Silva, G. P. D. L., Aleixo, M. M., Simão, D. F., Holtkamp, S., Lobo, D. D., Harish, P., Jenkins, R., Dahal, L. N., Nobre, R. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.07.662807

Authors: McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M.
Affiliations: University of California, Irvine (US)
Corresponding author: Blurton-Jones, Mathew
ORCID: McQuade, Amanda
Coburn, Morgan
Tu, Christina H.
Hasselmann, Jonathan
Davtyan, Hayk
Blurton-Jones, Mathew
Venue: Molecular Neurodegeneration
Publisher: Springer Science and Business Media LLC
Published: 2018-12
Volume: 13
Issue: 1
Pages: 67-67
ISSN: 1750-1326 (ISSN-L)
DOI: 10.1186/s13024-018-0297-x
PMC: PMC6303871
OpenAlex: W2905656859
Cited by: 449
References: 33
Citations by year: 2026: 64 · 2025: 98 · 2024: 73 · 2023: 53 · 2022: 54 · 2021: 43 · 2020: 40 · 2019: 23
FWCI: 11.92
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 21 d)
Locations: Molecular Neurodegeneration (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, other-oa)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: National Institutes of Health (AG048099, AG056303, AG016573)
California Institute for Regenerative Medicine (RT3-07893)
National Institute of Neurological Disorders and Stroke (NS082174)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: microglia differentiation, induced pluripotent stem cells, iPSC-derived microglia, hematopoietic progenitor cells, macrophage colony-stimulating factor, IL-34, TGF-β1, TGF-beta signaling, microglial transcriptome, neurodegeneration
MeSH terms: Animals, Brain, Cell Differentiation, Humans, Cytokines, Microglia, Pluripotent Stem Cells, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development and validation of a simplified method to generate human microglia from pluripotent stem cells

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks